Buprenorphine Transdermal Patch Suppliers & Bulk Manufacturers
Available Forms: Transdermal Patch
Available Strengths: 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr
Reference Brands: Butrans(US)
Category:
Analgesic
Buprenorphine transdermal patches activate mu-opioid receptors, blocking pain signals and altering pain perception for sustained relief. Benefits include long-lasting, effective pain control, improved patient adherence due to convenience, and a lower risk of overdose compared to other opioids when used responsibly and monitored carefully.
Buprenorphine Transdermal Patch is available in Transdermal Patch
and strengths such as 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Buprenorphine Transdermal Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Buprenorphine Transdermal Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Buprenorphine transdermal patches are approved in both the EU and US for managing severe pain. In the EU, brands like Butrans are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and rigorous manufacturing standards. In the US, FDA approval is based on extensive clinical data; generics are also available. Both regions enforce strict regulations, including prescribing controls and pharmacovigilance due to the potential for abuse. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine patches, ensuring adherence to European and American standards for safe, effective pain management in opioid-tolerant patients.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing